Prenatal Diagnosis and Postnatal Outcomes of Fetal ADPKD: A Single-Center Retrospective Cohort Study

Suhra Kim1, Ju-Hee Yoon1, Yun Ji Jung1

  • 1Department of Obstetrics and Gynecology, Institute of Women's Medical Life Science, Yonsei University College of Medicine, Yonsei University Health System, Seoul 03722, Republic of Korea.

PubMed

Insights

Prenatal ultrasound can identify fetal Autosomal Dominant Polycystic Kidney Disease (ADPKD). Loss of corticomedullary differentiation (CMD) on prenatal imaging may indicate poor long-term kidney function in infants with ADPKD.

Area of Science:

  • Nephrology
  • Medical Imaging
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary kidney disorder.
  • Antenatal diagnosis of ADPKD is rare but requires better understanding of postnatal outcomes.
  • Prenatal ultrasonography advances necessitate improved prognostic assessment and genetic counselling for fetal ADPKD.

Purpose of the Study:

  • To evaluate prenatal sonographic features of fetal ADPKD.
  • To correlate these prenatal findings with postnatal clinical and genetic outcomes.
  • To improve prognostic assessment and prenatal counselling for ADPKD.

Main Methods:

  • Retrospective review of 20 prenatally suspected ADPKD cases.
  • Analysis of prenatal ultrasound findings: renal size, echogenicity, CMD, cysts.
  • Correlation of sonographic features with postnatal renal function and CKD progression over a median of 93.6 months.

Main Results:

  • Consistent prenatal findings: increased cortical echogenicity (85%), increased CMD (75%), renal enlargement (35%).
  • Cortical cysts detected in 45%; amniotic fluid preserved in 80%.
  • Most infants had preserved renal function; two progressed to CKD, both with absent prenatal CMD. ARPKD-like features correlated with adverse outcomes.

Conclusions:

  • Fetal ADPKD presents with varied postnatal outcomes.
  • Loss of CMD and ARPKD-like sonograms suggest adverse prognosis.
  • Early ADPKD recognition is vital for counselling, perinatal care, and surveillance.